摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-2-Amino-3-[7-(2-butynyl)-1-methyl-6-oxo-8-(piperazin-1-yl)-6,7-dihydro-1H-purin-2-ylsulfanyl]propionic acid trifluoroacetate | 635718-21-7

中文名称
——
中文别名
——
英文名称
(R)-2-Amino-3-[7-(2-butynyl)-1-methyl-6-oxo-8-(piperazin-1-yl)-6,7-dihydro-1H-purin-2-ylsulfanyl]propionic acid trifluoroacetate
英文别名
(2R)-2-amino-3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)sulfanylpropanoic acid;2,2,2-trifluoroacetic acid
(R)-2-Amino-3-[7-(2-butynyl)-1-methyl-6-oxo-8-(piperazin-1-yl)-6,7-dihydro-1H-purin-2-ylsulfanyl]propionic acid trifluoroacetate化学式
CAS
635718-21-7
化学式
C2HF3O2*C17H23N7O3S
mdl
——
分子量
519.505
InChiKey
CMEJOTSIFKKROO-MERQFXBCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    35
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    192
  • 氢给体数:
    4
  • 氢受体数:
    14

文献信息

  • Condensed imidazole derivatives
    申请人:Eisai Co., Ltd.
    公开号:US20040116328A1
    公开(公告)日:2004-06-17
    The present invention is related to compounds represented by the following formula, or salts or hydrates thereof 1 wherein, T 1 represents a 4- to 12-membered heterocyclic group containing one or two nitrogen atoms in the ring, which is a monocyclic or bicyclic structure that may have one or more substituents; X represents a C 1-6 alkyl group which may have one or more substituents, or such; Z 1 and Z 2 each independently represent a nitrogen atom or a group represented by the formula —CR 2 —; R 1 and R 2 independently represent a hydrogen atom, a C 1-6 alkyl group which may have one or more substituents, or a C 1-6 alkoxy group which may have one or more substituents, or such. These are novel compounds that exhibit an excellent DPPIV-inhibiting activity.
    本发明涉及以下公式所代表的化合物,或其盐或合物 其中, T 1 代表一个含有一个或两个氮原子的4-至12-成员杂环基团,在环中是单环或双环结构,可能具有一个或多个取代基; X代表一个C 1-6 烷基基团,可能具有一个或多个取代基,或类似物; Z 1 和Z 2 各自独立地代表一个氮原子或由公式—CR 2 —所代表的基团; R 1 和R 2 独立地代表氢原子,一个C 1-6 烷基基团,可能具有一个或多个取代基,或一个C 1-6 烷氧基基团,可能具有一个或多个取代基,或类似物。 这些是表现出优异DPPIV抑制活性的新颖化合物。
  • Novel condensed imidazole derivatives
    申请人:Yoshikawa Seiji
    公开号:US20060100199A1
    公开(公告)日:2006-05-11
    The present invention is related to compounds represented by the following formula, or salts or hydrates thereof wherein, T 1 represents a 4- to 12-membered heterocyclic group containing one or two nitrogen atoms in the ring, which is a monocyclic or bicyclic structure that may have one or more substituents; X represents a C 1-6 alkyl group which may have one or more substituents, or such; Z 1 and Z 2 each independently represent a nitrogen atom or a group represented by the formula —CR 2 —; R 1 and R 2 independently represent a hydrogen atom, a C 1-6 alkyl group which may have one or more substituents, or a C 1-6 alkoxy group which may have one or more substituents, or such. These are novel compounds that exhibit an excellent
    本发明涉及以下式子所表示的化合物、盐或合物:其中,T1代表一个含有一个或两个氮原子的4-至12元杂环基团,它是一个单环或双环结构,可能有一个或多个取代基;X代表一个C1-6烷基基团,它可能有一个或多个取代基,或者如此;Z1和Z2各自独立地代表一个氮原子或者由公式—CR2—所表示的基团;R1和R2各自独立地代表一个氢原子,一个C1-6烷基基团,它可能有一个或多个取代基,或者一个C1-6烷氧基基团,它可能有一个或多个取代基,或者如此。这些是新颖的化合物,具有优异的性能。
  • CONDENSED IMIDAZOLE DERIVATIVES
    申请人:Yoshikawa Seiji
    公开号:US20090018331A1
    公开(公告)日:2009-01-15
    The present invention is related to compounds represented by the following formula, or salts or hydrates thereof wherein, T 1 represents a 4- to 12-membered heterocyclic group containing one or two nitrogen atoms in the ring, which is a monocyclic or bicyclic structure that may have one or more substituents; X represents a C 1-6 alkyl group which may have one or more substituents, or such; Z 1 and Z 2 each independently represent a nitrogen atom or a group represented by the formula —CR 2 —; R 1 and R 2 independently represent a hydrogen atom, a C 1-6 alkyl group which may have one or more substituents, or a C 1-6 alkoxy group which may have one or more substituents, or such. These are novel compounds that exhibit an excellent DPPIV-inhibiting activity.
    本发明涉及下式所示的化合物、盐或合物: 其中, T1表示一个4-到12成员的杂环基团,在环中含有一个或两个氮原子,是单环或双环结构,可以有一个或多个取代基; X表示一个C1-6烷基基团,可以有一个或多个取代基; Z1和Z2各自独立地表示一个氮原子或由公式—CR2—表示的基团; R1和R2各自独立地表示氢原子、一个C1-6烷基基团,可以有一个或多个取代基,或一个C1-6烷氧基基团,可以有一个或多个取代基。 这些是具有出色的DPPIV抑制活性的新型化合物。
  • NOVEL FUSED IMIDAZOLE DERIVATIVE
    申请人:Eisai Co., Ltd.
    公开号:EP1514552A1
    公开(公告)日:2005-03-16
    The present invention is related to compounds represented by the following formula, or salts or hydrates thereof wherein, T1 represents a 4- to 12-membered heterocyclic group containing one or two nitrogen atoms in the ring, which is a monocyclic or bicyclic structure that may have one or more substituents; X represents a C1-6 alkyl group which may have one or more substituents, or such; Z1 and Z2 each independently represent a nitrogen atom or a group represented by the formula -CR2-; R1 and R2 independently represent a hydrogen atom, a C1-6 alkyl group which may have one or more substituents, or a C1-6 alkoxy group which may have one or more substituents, or such. These are novel compounds that exhibit an excellent DPPIV-inhibiting activity.
    本发明涉及下式所代表的化合物或其盐类或合物 其中 T1 代表环中含有一个或两个氮原子的 4 至 12 元杂环基团,其为单环或双环结构,可具有一个或多个取代基; X 代表可带有一个或多个取代基的 C1-6 烷基,或此类; Z1和Z2各自独立地代表一个氮原子或一个由式-CR2-代表的基团; R1和R2各自独立地代表氢原子、C1-6烷基(可带有一个或多个取代基)或C1-6烷氧基(可带有一个或多个取代基)或此类基团。 这些新型化合物具有优异的 DPPIV 抑制活性。
  • US7772226B2
    申请人:——
    公开号:US7772226B2
    公开(公告)日:2010-08-10
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸